La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !

Micropos Medical Bilan de santé

Santé financière contrôle des critères 5/6

Micropos Medical possède un total de capitaux propres de SEK8.5M et une dette totale de SEK382.0K, ce qui porte son ratio d'endettement à 4.5%. Son actif total et son passif total sont SEK15.8M et de SEK7.3M.

Informations clés

4.5%

Ratio d'endettement

SEK 382.00k

Dette

Ratio de couverture des intérêts	n/a
Argent liquide	SEK 6.02m
Fonds propres	SEK 8.53m
Total du passif	SEK 7.30m
Total des actifs	SEK 15.82m

Mises à jour récentes de la santé financière

Recent updates

We're Keeping An Eye On Micropos Medical's (NGM:MPOS) Cash Burn Rate

Jul 30

We're Not Very Worried About Micropos Medical's (NGM:MPOS) Cash Burn Rate

May 11

Will Micropos Medical (NGM:MPOS) Spend Its Cash Wisely?

Sep 04

Here's Why We're Watching Micropos Medical's (NGM:MPOS) Cash Burn Situation

May 20

Chairman Ove Mattsson Just Bought 16% More Shares In Micropos Medical AB (publ) (NGM:MPOS)

Mar 13

Have Insiders Been Buying Micropos Medical AB (publ) (NGM:MPOS) Shares?

Dec 14

Analyse de la situation financière

Passif à court terme: Les actifs à court terme de MPOS ( SEK13.2M ) dépassent ses passifs à court terme ( SEK6.9M ).

Passif à long terme: Les actifs à court terme de MPOS ( SEK13.2M ) dépassent ses passifs à long terme ( SEK382.0K ).

Historique et analyse du ratio d'endettement

Niveau d'endettement: MPOS dispose de plus de liquidités que de sa dette totale.

Réduire la dette: Le ratio d'endettement de MPOS est passé de 3.4% à 4.5% au cours des 5 dernières années.

Bilan

Analyse des pistes de trésorerie

Pour les entreprises qui ont été en moyenne déficitaires dans le passé, nous évaluons si elles disposent d'au moins un an de trésorerie.

Piste de trésorerie stable: MPOS dispose d'une piste de trésorerie suffisante pour 3 mois sur la base du dernier flux de trésorerie disponible, mais a depuis levé des capitaux supplémentaires.

Prévisions de trésorerie: MPOS devrait disposer d'une marge de trésorerie suffisante pour 3 mois sur la base des estimations de flux de trésorerie disponible, mais a depuis levé des capitaux supplémentaires.

Micropos Medical Bilan de santé

Santé financière contrôle des critères 5/6

Informations clés

Mises à jour récentes de la santé financière

We're Keeping An Eye On Micropos Medical's (NGM:MPOS) Cash Burn Rate

We're Not Very Worried About Micropos Medical's (NGM:MPOS) Cash Burn Rate

Will Micropos Medical (NGM:MPOS) Spend Its Cash Wisely?

Here's Why We're Watching Micropos Medical's (NGM:MPOS) Cash Burn Situation

Recent updates

Micropos Medical AB (publ) to Report Q2, 2024 Results on Jul 31, 2024

Micropos Medical AB (publ), Annual General Meeting, May 29, 2024

Micropos Medical AB (publ) to Report Q1, 2024 Results on Apr 30, 2024

Micropos Medical AB (publ) has filed a Follow-on Equity Offering.

Full year 2023 earnings released: kr0.17 loss per share (vs kr0.15 loss in FY 2022)

Micropos Medical AB (publ) to Report Fiscal Year 2023 Results on Jan 31, 2024

Chairman recently bought kr171k worth of stock

Chairman recently bought kr211k worth of stock

Third quarter 2023 earnings released

Micropos Medical AB (publ) to Report Q3, 2023 Results on Oct 26, 2023

Chief Executive Officer recently bought kr460k worth of stock

Chairman recently bought kr139k worth of stock

Chairman recently bought kr419k worth of stock

We're Keeping An Eye On Micropos Medical's (NGM:MPOS) Cash Burn Rate

New major risk - Financial position

Second quarter 2023 earnings released

New minor risk - Share price stability

Micropos Medical AB (publ) to Report First Half, 2023 Results on Jul 27, 2023

Chairman recently bought kr498k worth of stock

First quarter 2023 earnings released

Chairman recently bought kr293k worth of stock

Chairman recently bought kr169k worth of stock

Chairman recently bought kr129k worth of stock

Full year 2022 earnings released: kr0.15 loss per share (vs kr0.12 loss in FY 2021)

Micropos Medical AB (publ) has completed a Follow-on Equity Offering in the amount of SEK 24.978994 million.

Micropos Medical AB (publ) to Report Fiscal Year 2022 Results on Jan 30, 2023

Chairman recently bought kr9.4m worth of stock

No independent directors

Third quarter 2022 earnings released

Second quarter 2022 earnings released: kr0.04 loss per share (vs kr0.04 loss in 2Q 2021)

We're Not Very Worried About Micropos Medical's (NGM:MPOS) Cash Burn Rate

First quarter 2022 earnings released

No independent directors

Full year 2021 earnings: Revenues and EPS in line with analyst expectations

Third quarter 2021 earnings: Revenues in line with analyst expectations

Second quarter 2021 earnings released: kr0.04 loss per share (vs kr0.04 loss in 2Q 2020)

Will Micropos Medical (NGM:MPOS) Spend Its Cash Wisely?

Chairman exercised options to buy kr367k worth of stock.

Here's Why We're Watching Micropos Medical's (NGM:MPOS) Cash Burn Situation

First quarter 2021 earnings released: kr0.03 loss per share (vs kr0.011 loss in 1Q 2020)

Chairman recently bought kr8.6m worth of stock

Chairman Ove Mattsson Just Bought 16% More Shares In Micropos Medical AB (publ) (NGM:MPOS)

Full year 2020 earnings released: kr0.11 loss per share (vs kr0.14 loss in FY 2019)

New 90-day high: kr3.12

Chairman recently bought kr987k worth of stock

Have Insiders Been Buying Micropos Medical AB (publ) (NGM:MPOS) Shares?

Third quarter 2020 earnings released: kr0.03 loss per share

New 90-day low: kr2.46

First half earnings released

New 90-day high - kr3.56

Micropos Medical AB (publ) has completed a Follow-on Equity Offering in the amount of SEK 12.734349 million.

Analyse de la situation financière

Historique et analyse du ratio d'endettement

Bilan

Analyse des pistes de trésorerie

Découvrir des entreprises saines